Jinchuang Li
Guangzhou, 510180, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The FGFRL1-FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer.
Journal: Cancer letters
Published: April 02, 2026
Regulatory B cells and SIVA1-LAG3 immune suppression predict poor prognosis in prostate cancer.
Journal: Biomolecules & biomedicine
Published: February 25, 2026
Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.
Journal: Translational andrology and urology
Published: August 01, 2025
ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.
Journal: Cell communication and signaling : CCS
Published: April 24, 2025
Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.
Journal: Cancer letters
Published: February 26, 2025
A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer.
Journal: Journal of Cancer
Published: February 21, 2025
Precision targeted melanoma therapy via cuproptosis/chemodynamic and chemotherapy: An engineering MCHS-CuMOF nanodelivery system.
Journal: Biomaterials advances
Published: November 18, 2024
Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.
Journal: Cancer medicine
Published: October 11, 2024
N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification.
Journal: International immunopharmacology
Published: April 22, 2024
Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.
Journal: MedComm
Published: March 15, 2024
Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer.
Journal: Frontiers in endocrinology
Published: January 20, 2023
Last Updated: 09/26/2026